NewSquare Capital’s Moderna MRNA Stock Holding History

NewSquare Capital’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-87	Closed	-$2.4K	–	826
2025 Q2	$2.4K	Sell	87 -43	-33%	-$1.13K	﹤0.01%	933
2025 Q1	$3.69K	Buy	130 +124	+2,067%	+$4.4K	﹤0.01%	745
2024 Q4	$249	Buy	+6	New	+$287	﹤0.01%	851
2023 Q3	–	Sell	-8	Closed	-$972	–	776
2023 Q2	$972	Hold	8	–	–	﹤0.01%	613
2023 Q1	$1.23K	Hold	8	–	–	﹤0.01%	629
2022 Q4	$1.44K	Buy	8 +4	+100%	+$654	﹤0.01%	532
2022 Q3	$0	Buy	+4	New	+$607	﹤0.01%	456

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

NewSquare Capital's MRNA Position: Q3 2025 in Review

NewSquare Capital sold out of Moderna (MRNA) in Q3 2025, closing a stake of 87 shares — an estimated $2.4K sold.

NewSquare Capital first reported a position in MRNA in Q3 2022 and held it in 7 quarters. The position peaked at $3.69K in Q1 2025. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

NewSquare Capital reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
NewSquare Capital sold 87 Moderna shares in Q3 2025, an estimated $2.4K.
NewSquare Capital first reported a position in Moderna in Q3 2022 and held it in 7 quarters.
NewSquare Capital's Moderna position peaked at $3.69K in Q1 2025.
643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.